ACLY and hepatocellular carcinoma: Genetic inhibition of ACLY increased tumour infiltration by B cells and upregulated the B cell chemoattractant CXCL13, promoting the formation of TLSs, immune niches associated with favourable prognosis in HCC and other solid tumours17,43,45–47.